Showing results (11-20 of 117) with videos related to
Sort By:
Pageof 12
BMC Medical Genetics|July 18, 2012
Identification of 3 novel VHL germ-line mutations in Danish VHL patientsMette Dandanell, Lennart Friis-Hansen, Lone Sunde, et al.Clinical Case Reports|June 8, 2017
Classification of the spliceogenic BRCA1 c.4096+3A>G variant as likely benign based on cosegregation data and identification of a healthy homozygous carrierAnna Byrjalsen, Ane Y Steffensen, Thomas V O Hansen, et al.Cell Reports|April 8, 2014
IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and developmentLars Jønson, Jan Christiansen, Thomas V O Hansen, et al.The Biochemical Journal|March 21, 2002
Human insulin-like growth factor II leader 2 mediates internal initiation of translationSusanne K Pedersen, Jan Christiansen, Thomas v O Hansen, et al.Familial Cancer|January 7, 2014
Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational studyLinda Bardram, Thomas V O Hansen, Anne-Marie Gerdes, et al.Breast Cancer Research and Treatment|June 12, 2008
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer familiesThomas v O Hansen, Lars Jønson, Anders Albrechtsen, et al.Breast Cancer Research and Treatment|March 1, 2015
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenicLise B Ahlborn, Mette Dandanell, Ane Y Steffensen, et al.Molecular and Cellular Biology|September 17, 2005
Control of fetal growth and neonatal survival by the RasGAP-associated endoribonuclease G3BPLatifa Zekri, Karim Chebli, Hélène Tourrière, et al.Breast Cancer Research and Treatment|March 10, 2009
The silent mutation nucleotide 744 G --> A, Lys172Lys, in exon 6 of BRCA2 results in exon skippingThomas V O Hansen, Ane Y Steffensen, Lars Jønson, et al.Familial Cancer|May 11, 2010
Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutationsAne Y Steffensen, Lars Jønson, Bent Ejlertsen, et al.Pageof 12